Medine.co.uk

Out of date information, search another

Superdrug Indigestion Relief Liquid

Out of date information, search another
Informations for option: Superdrug Indigestion Relief Liquid, show other option

SUMMARY OF PRODUCT CHARACTERISTICS

1    NAME OF THE MEDICINAL PRODUCT

SUPERDRUG INDIGESTION RELIEF LIQUID

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 5ml dose contains:

Aluminium Hydroxide Gel BP:    220mg

Magnesium Hydroxide BP:    195mg

3    PHARMACEUTICAL FORM

Suspension for oral administration

4    CLINICAL PARTICULARS

4.1    Therapeutic indications

Antacid therapy in gastric and duodenal ulcer, gastritis, heartburn, gastric hyperacidity. Treatment of indigestion.

4.2 Posology and method of administration

Adults and the Elderly:

10-20ml three times daily, 20 minutes to one hour after meals, and at bedtime, or as required.

4.3 Contraindications

Should not be used in patients who are severely debilitated or suffering from kidney failure.

4.4 Special warnings and precautions for use

None stated.

4.5 Interaction with other medicinal products and other forms of interaction

Antacids inhibit the absorption of tetracyclines and vitamins and should not be taken concomitantly.

4.6 Pregnancy and lactation

For Superdrug Indigestion Relief Liquid no clinical data on exposed pregnancies are available.

Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embroynal/foetal development, parturition or postnatal development.

Caution should be exercised when prescribing to pregnant women.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Gastrointestinal side-effects are uncommon. This formulation minimises the problems of diarrhoea and constipation.

4.9 Overdose

Serious symptoms are unlikely to follow overdosage.

5    PHARMACOLOGICAL PROPERTIES

5.1    Pharmacodynamic properties

The product contains two established antacids, magnesium and aluminium hydroxides with an acid neutralising capacity in excess of 25ml of 0.1N HC1 consumed, per gram of suspension.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Sorbitol Solution 70%

Mannitol

Hydrochloric Acid Methyl P-Hydroxybenzoate Propyl P-Hydroxybenzoate Citric Acid

Simethicone Emulsion 30%

Saccharin Sodium

Hydrogen Peroxide 35% Solution

Peppermint Oil

Strong Sodium Hypochlorite Solution Purified Water

6.2 Incompatibilities

None known.

6.3 Shelf life

Unopened shelf life:    2 years

Opened shelf life:    28 days

6.4 Special precautions for storage

Store below 25°C. Do not freeze.

Use within 28 days of opening.

6.5 Nature and contents of container

High-density polyethylene bottle with a polypropylene closure fitted with a tamper evident ring.

The pack sizes are 100ml, 300ml and 500ml.

6.6 Special precautions for disposal

None.

7    MARKETING AUTHORISATION HOLDER

CHEMIDEX PHARMA LIMITED

CHEMIDEX HOUSE, EGHAM BUSINESS VILLAGE

CRABTREE ROAD

EGHAM

SURREY

TW20 8RB

UNITED KINGDOM

8    MARKETING AUTHORISATION NUMBER(S)

PL 17736/0114

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

25 November 1987 / 25 November 1997

10 DATE OF REVISION OF THE TEXT

26/03/2008